NEW YORK (GenomeWeb) – Tauriga Sciences said on Thursday that it completed a $600,000 private placement with unnamed institutional and accredited individual investors.
The proceeds will be directed in part to advance the commercialization of the synthetic biology technology platform of its wholly owned subsidiary, Pilus Energy, for industrial wastewater remediation. The platform, called the Electrogenic Bioreaction system, harnesses genetically enhanced bacteria.
Tauriga, headquartered in Danbury, Conn., is a diversified company focused on the development of a nano-robotics technology platform. Proceeds will also go toward other working capital purposes, including growing the revenues of its natural wellness businesses, it said.
Tauriga also said that Tokyo-based Dragoon Capital has invested a total of $350,000 in the company, though it did not specify that Dragoon participated in the most recent financing.